Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients

Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline mutations in BRCA1/2 genes are present in 13–18% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallardo-Rincón, Dolores, Álvarez-Gómez, Rosa María, Montes-Servín, Edgar, Toledo-Leyva, Alfredo, Montes-Servín, Elizabeth, Michel-Tello, David, Alamilla-García, Gabriela, Bahena-González, Antonio, Hernández-Nava, Elizabeth, Fragoso-Ontiveros, Veronica, Espinosa-Romero, Raquel, Cetina-Pérez, Lucely
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931216/
https://www.ncbi.nlm.nih.gov/pubmed/31869745
http://dx.doi.org/10.1016/j.tranon.2019.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931216/
https://www.ncbi.nlm.nih.gov/pubmed/31869745
http://dx.doi.org/10.1016/j.tranon.2019.11.003

Ejemplares similares